Hemihyperplasia–multiple lipomatosis syndrome

Hemihyperplasia–multiple lipomatosis syndrome
Synonyms	Hemihypertrophy-multiple lipomatosis syndrome
Pronounce	N/A
Specialty	N/A
Symptoms	Asymmetry of the body, multiple lipomas
Complications	Potential for malignancy in overgrown tissues
Onset	Congenital
Duration	Lifelong
Types	N/A
Causes	Genetic mutation
Risks	Increased risk of cancer
Diagnosis	Clinical diagnosis, genetic testing
Differential diagnosis	Proteus syndrome, Beckwith-Wiedemann syndrome
Prevention	N/A
Treatment	Surgical removal of lipomas, monitoring for malignancy
Medication	N/A
Prognosis	Variable, depends on extent of overgrowth and complications
Frequency	Rare
Deaths	N/A

Hemihyperplasia–multiple lipomatosis syndrome is a rare genetic disorder characterized by overgrowth of one side of the body and multiple lipomas. The syndrome is also known as hemihypertrophy-multiple lipomatosis syndrome.

Symptoms

The primary symptoms of Hemihyperplasia–multiple lipomatosis syndrome include hemihypertrophy and multiple lipomas. Hemihypertrophy refers to the overgrowth of one side of the body, which can affect a single limb, half of the body, or even a single region of the body. Lipomas are benign fatty tumors that can occur anywhere in the body.

Causes

The exact cause of Hemihyperplasia–multiple lipomatosis syndrome is unknown. However, it is believed to be a genetic disorder, possibly caused by mutations in certain genes. The syndrome is not typically inherited, but rather occurs as a new mutation in the affected individual.

Diagnosis

Diagnosis of Hemihyperplasia–multiple lipomatosis syndrome is based on the presence of the characteristic symptoms of hemihypertrophy and multiple lipomas. Imaging studies such as ultrasound, CT scan, or MRI may be used to confirm the presence of lipomas.

Treatment

There is no cure for Hemihyperplasia–multiple lipomatosis syndrome. Treatment is aimed at managing the symptoms and may include surgery to remove lipomas if they are causing discomfort or functional impairment. Regular monitoring is recommended to detect any potential complications, such as the development of malignancies.

See also

• Hemihypertrophy
• Lipoma
• Genetic disorder